Misc. news stories
After a shock injury on a reef in Indonesia in 2018, he pushed into frontiers that athletes, let alone modern science, are only just beginning to explore.
Image from: Shalom Jacobovitz (Wiki Commons)
“I had the full-blown mystical revelatory experience – the big psychedelic multi-coloured light and sound show.” This is how Steve recalls his first dose of a hallucinogenic drug, psilocybin…
Psilocybin, a drug found in magic mushrooms, appears to free up the brains of people with severe depression in a way that other antidepressants do not, a study has found.
For the past several decades, psychedelics have been widely stigmatized as dangerous illegal drugs. But a recent surge of academic research into their use to treat psychiatric conditions is spurring a recent shift in public opinion.
The psychedelic substance psilocybin causes transient changes to the sleep-wake architecture of laboratory mice, according to new preliminary research published in Translational Psychiatry. The findings provide new details about how the drug impacts sleep-related brain activity.
The findings, published March 28 in Frontiers in Psychology, reveal that higher ratings of mystical-type experiences, which often include a sense that everything is alive, were associated with greater increases in the attribution of consciousness.
Image from: Air article (Wiki Commons)
Applying machine learning to a database of testimonials uncovers how drug-induced changes in subjective awareness are mechanistically rooted in the human brain.
Our ability to elaborately communicate is one of humanity’s greatest superpowers. It allows us to retain and build knowledge across generations, cooperating at a global scale unlike anything else seen on Earth. But much about how this ability evolved is still a mystery, including its origins.
New research provides evidence that MDMA-assisted psychotherapy can improve and extend lives of patients with chronic and severe posttraumatic stress disorder while also reducing healthcare costs. The findings have been published in the journal PLOS One.
People suffering debilitating cluster headaches say the active ingredient in magic mushrooms is a help.
What happens inside your brain during these experiences and after death are questions that have puzzled neuroscientists for centuries. However, a new study published to Frontiers in Aging Neuroscience suggests that your brain may remain active and coordinated during and even after the transition to death, and be programmed to orchestrate the whole ordeal.
The accidental finding was made when a man suddenly died during a routine brain scan.
New study examines the paradoxical relationships between psychosis, psychotherapy, and psychedelic experiences.
The study of false—sober—insights teaches us to be wary of accepting every realization from psychedelic trips without critical thinking.
A new study published in Frontiers in Psychology provides an in-depth look at the types of otherworldly experiences that people have when they take a high dose of the psychedelic substance dimethyltryptamine (DMT). The findings provide new insight on the complex dimensions of the DMT experience.
New neuroimaging research sheds light on the brain regions involved in extracting structure from past experiences when making decisions. The study, which appears in Cell Reports, indicates that the hippocampus and orbitofrontal cortex play key roles in this process.